Cleveland Biolabs, Inc.
Records under this name other than patents Cleveland Biolabs, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Cleveland Biolabs, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,108,916 | Carbazole Compounds and Therapeutic Uses of the Compounds Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,242,057 | Methods for Identifying Modulators of Apoptosis Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 10,137,109 | Carbazole Compounds and Therapeutic Uses of the Compounds Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,034,926 | Use of Toll-Like Receptor Agonist for Treating Cancer Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,265,390 | Use of Toll-Like Receptor Agonist for Treating Cancer Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,780,152 | Use of Toll-Like Receptor Agonist for Treating Cancer Formerly held In force (reinstated) · Medium confidence | In force (reinstated) | Medium confidence | |
| US 9,376,473 | Use of Toll-Like Receptor Agonist for Treating Cancer Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 11,628,201 | Use of Toll-Like Receptor Agonist for Treating Cancer Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,202,426 | Flagellin Compositions and Uses Formerly held In force · High confidence | In force | High confidence | |
| US 10,336,793 | Flagellin-based agents and uses including effective vaccination Formerly held In force · USPTO record | In force | USPTO record |